Hasan Hashem
Overview
Explore the profile of Hasan Hashem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makoseh M, Rahman Z, Yaseen A, Mesmar A, Abu-Jazar H, Saadeh S, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Feb;
PMID: 40011099
Introduction: Peripheral blood (PB) grafts are increasingly used in haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplant cyclophosphamide (PT-Cy). The optimal timing for initiation of immunosuppression (IS) with calcineurin inhibitors...
2.
Hashem H, Ghatasheh L, Najjar R, Mufarrej D, Zandaki D, Abu Shanap M, et al.
J Clin Immunol
. 2024 Dec;
45(1):59.
PMID: 39729175
Inborn errors of immunity (IEI) are a heterogenous group of rare monogenic disorders that affect innate or adaptive immunity, resulting in susceptibility to life-threatening infections and autoimmunity. Allogeneic hematopoietic cell...
3.
Halahleh K, Makoseh M, Taqash A, Abuhijla F, Ghatasheh L, Al Far R, et al.
Clin Hematol Int
. 2024 Oct;
6(4):1-10.
PMID: 39417015
Background: Total body irradiation (TBI) with or without cranial radiation boost (CRB) is an integral component of conditioning prior to allogeneic hematopoietic cell transplantation (allo-HCT) in acute lymphoblastic leukemia (ALL)....
4.
Hashem H
Lancet Child Adolesc Health
. 2024 Sep;
8(10):709-711.
PMID: 39217998
No abstract available.
5.
Ballen K, Wang T, He N, Knight J, Hong S, Frangoul H, et al.
Transplant Cell Ther
. 2024 Jul;
30(10):1027.e1-1027.e14.
PMID: 39033978
Background: Umbilical cord blood transplant (UCBT) improves access to transplant for patients lacking a fully matched donor. Previous Center for International Blood and Marrow Transplant Research (CIBMTR) showed that Black...
6.
Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, et al.
Blood Adv
. 2024 Apr;
8(13):3497-3506.
PMID: 38661372
There has been an increase in volume as well as an improvement in overall survival (OS) after hematopoietic cell transplantation (HCT) for hematologic disorders. It is unknown if these changes...
7.
Knight T, Ahn K, Hebert K, Atshan R, Wall D, Chiengthong K, et al.
Bone Marrow Transplant
. 2023 Sep;
58(12):1390-1393.
PMID: 37666957
No abstract available.
8.
Santos P, Hashem H, Zama D
Front Pediatr
. 2023 Aug;
11:1254343.
PMID: 37576137
No abstract available.
9.
Blue B, Brazauskas R, Chen K, Patel J, Zeidan A, Steinberg A, et al.
Transplant Cell Ther
. 2023 Jul;
29(11):709.e1-709.e11.
PMID: 37482244
Racial/ethnic minorities have demonstrated worse survival after allogeneic hematopoietic cell transplantation (HCT) compared to whites. Whether the racial disparity in HCT outcomes persists in long-term survivors and possibly may be...
10.
Muffarrej D, Hashem H, Tbakhi A, Najjar R
J Oncol Pharm Pract
. 2023 Jun;
:10781552231171829.
PMID: 37357617
Introduction: Filgrastim is used for the mobilization of stem cells in healthy donors. Though several biosimilar filgrastim products have been approved, there is limited literature evaluating biosimilar products for stem...